M1 agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease

Antonella Caccamo, Abraham Fisher, Frank M. Laferla

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'M1 agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences